The Whelan Lab
Research in the Whelan lab is motivated by the need to detect and treat ovarian cancer in its early stages. We approach the problem of ovarian cancer detection with a diverse tool kit drawn from bioanalytical chemistry, molecular biology, bioinformatics, and nanoscience.
Recent Whelan Group News
April 22, 2024 - Eliza's most recent paper, "Combining the benefits of biotin-streptavidin aptamer immobilization with the versatility of Ni-NTA regeneration strategies for SPR" has been accepted for publication in Sensors. Congratulations, Eliza!
April 19, 2024 - Eliza successfully defended her dissertation, "Surface plasmon resonance method optimization and instrumental variability investigation: mapping antibody recognition of CA125." Congratulations, Dr. Hanson!
April 17, 2024 - Naviya successfully defended her dissertation, "Development of sample preparation methods to characterize clinically relevant biomarkers using mass spectrometry." Congratulations, Dr. Schuster-Little!
April 15, 2024 - Chien-Wei has been selected as the recipient of the 2024 Newmark Award. The award honors the memory of Dr. Marjorie Newmark and Dr. Philip Newmark, two KU biochemistry professors, and is given to a KU graduate student for excellence in biochemical research. Congratulations, Chien-Wei!
April 15, 2024 - Our project "Clarifying the roles of glycoprotein sequence and cancer cell phenotype on the immunogenicity of ovarian cancer biomarker CA125," has been funded as part of the new NIH COBRE on Leveraging Big Data for Women's Health. We are thrilled to have this opportunity!